Research
What research is being done for pancreatic cancer treatments and screenings today? The next life-saving treatment for the disease may be on the horizon. These articles highlight the latest in pancreatic cancer research.
362 Articles
Large Phase III Global Trial Targets Cancer Metabolism
Dr. Philip Philip focuses on disrupting cancer cell metabolism with devimistat, now in a phase III global clinical trial.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
Finding More Clues about Circulating Tumor DNA
Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.
Identifying Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Reducing Pancreatic Cancer Risk Through Chemoprevention
Dr. Peter Allen leads a clinical trial of chemoprevention–the use of a medication to prevent IPMNs from developing into pancreatic cancer.
Will New-Onset Diabetes Provide a Way to Detect Pancreatic Cancer Earlier?
Dr. Anirban Maitra, Dr. Suresh Chari, and others are looking at the relationship between new-onset diabetes and pancreatic cancer.
CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers
CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.
New-Onset Diabetes Plus Unintentional Weight Loss Emerging as an Important Clue In Earlier Detection
Dr. Brian Wolpin outlines the connection between unintentional weight loss, new-onset diabetes, and pancreatic cancer.
Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor
Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
Researching More Second-Line Options for Pancreatic Cancer
Dr. Allyson Ocean explains the concept behind a novel second-line treatment being tested for metastatic pancreatic cancer.
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
Improving Access to Genetic Testing and Counseling
Dr. Angela Bradbury is leading a study on access to genetic testing and genetic counseling, including a telehealth option.